• Health & Medicine

Cancer Research UK and Woman’s Own create special edition for GP surgeries

Cancer Research UK has partnered with Woman’s Own to create a special edition copy of the magazine that will be distributed solely to GP surgeries this summer. Cancer Research UK has partnered with Woman’s Own to create a special edition copy of the magazine that will be distributed solely to GP surgeries this summer.

13 April 2016

• Health & Medicine

Obesity behind big rise in womb cancer

Rising levels of obesity among UK women have helped fuel a 54 per cent increase in womb cancer rates over the last two decades, according to new statistics. Rising levels of obesity among UK women have helped fuel a 54 per cent increase in womb cancer rates over the last two decades, according to new statistics.

13 April 2016

• Health & Medicine

First cancer patient in Europe scanned in Cambridge using new technique showing whether drugs work

The first cancer patient in Europe has been scanned with technique that could enable doctors to see whether a drug is working within a few days. The first cancer patient in Europe has been scanned with technique that could enable doctors to see whether a drug is working within a few days.

11 April 2016

• Health & Medicine
• Science & Technology

US hospital commits to lung cancer ‘liquid biopsy’

Analysing tumour DNA in blood samples could help doctors offer ‘targeted’ treatments best suited to a patient’s lung cancer. Analysing tumour DNA in blood samples could help doctors offer ‘targeted’ treatments best suited to a patient’s lung cancer.

8 April 2016

• Health & Medicine

Scientists identify possible double whammy to attack leukaemia

Cancer Research UK scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia. Cancer Research UK scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia.

7 April 2016

• Health & Medicine
• Science & Technology

Immunotherapy and chemo combination shows early promise for pancreatic cancer

An experimental drug that stimulates the immune system, used in combination with chemotherapy, shrank tumours in patients with pancreatic cancer. An experimental drug that stimulates the immune system, used in combination with chemotherapy, shrank tumours in patients with pancreatic cancer.

6 April 2016

• Health & Medicine

Six ways to reduce your risk of bowel cancer

For bowel cancer awareness month we look at the different ways you can reduce your risk of the disease. For bowel cancer awareness month we look at the different ways you can reduce your risk of the disease.

5 April 2016

Making blood vessels ‘leaky’ could help treat children’s brain tumours

A new study published today by a group of scientists could explain why there are such differences in survival between medulloblastoma patients. A new study published today by a group of scientists could explain why there are such differences in survival between medulloblastoma patients.

1 April 2016

• Health & Medicine

9 in 10 don't link alcohol and cancer

Almost 90 per cent of people in England don’t associate drinking alcohol with an increased risk of cancer Almost 90 per cent of people in England don’t associate drinking alcohol with an increased risk of cancer

1 April 2016

• Science & Technology

Scientists discover new way to tackle challenging children’s brain tumours

Scientists have discovered why a curable type of children’s brain tumour is so responsive to chemotherapy. Scientists have discovered why a curable type of children’s brain tumour is so responsive to chemotherapy.

31 March 2016

• Health & Medicine

Reminder letter encourages more people to take bowel scope screening test

Jogging the memory with a reminder letter to those who don’t respond to their bowel scope screening invitation could mean more people would take the test. Jogging the memory with a reminder letter to those who don’t respond to their bowel scope screening invitation could mean more people would take the test.

30 March 2016

• Health & Medicine

Prostate cancer drug approved for routine use before chemotherapy

The National Institute for Health and Care Excellence (NICE) has approved the drug abiraterone for use before chemotherapy for prostate cancer The National Institute for Health and Care Excellence (NICE) has approved the drug abiraterone for use before chemotherapy for prostate cancer

21 March 2016